Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Guillevin

Showing results (471-480 of 541) with videos related to

Pageof 55
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patientsE Bajetta, N Zilembo, M Dowsett, et al.
Annals of the Rheumatic Diseases|May 16, 2007
Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scaleL Mouthon, F Rannou, A Bérezné, et al.
Transfusion Medicine (Oxford, England)|June 13, 2006
Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two casesA Berezné, N Stieltjes, V Le-Guern, et al.
La Revue De Medecine Interne|January 1, 1993
[Is the risk of pneumocystosis predictable in Wegener's disease?]B Godeau, J L Mainardi, E Hachulla, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1990
[Anti-Scl-70 antibodies in systemic scleroderma]Le Thi Huong, F Sauvaget, C Johanet, et al.
The European Respiratory Journal|June 16, 2006
Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertensionM C Tamby, M Humbert, P Guilpain, et al.
Rheumatology (Oxford, England)|September 7, 2007
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitisC Lapraik, R Watts, P Bacon, et al.
Annals of the Rheumatic Diseases|November 27, 2007
Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritisX Puéchal, C Miceli-Richard, O Mejjad, et al.
The European Respiratory Journal|April 13, 2007
Severity of scleroderma lung disease is related to alveolar concentration of nitric oxideK P Tiev, J Cabane, F Aubourg, et al.
La Revue De Medecine Interne|January 23, 2004
[Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis]C Georges, O Chassany, L Mouthon, et al.
Pageof 55

Showing results (471-480 of 541) with videos related to

Sort By:
Pageof 55
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patientsE Bajetta, N Zilembo, M Dowsett, et al.
Annals of the Rheumatic Diseases|May 16, 2007
Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in Systemic Sclerosis scaleL Mouthon, F Rannou, A Bérezné, et al.
Transfusion Medicine (Oxford, England)|June 13, 2006
Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two casesA Berezné, N Stieltjes, V Le-Guern, et al.
La Revue De Medecine Interne|January 1, 1993
[Is the risk of pneumocystosis predictable in Wegener's disease?]B Godeau, J L Mainardi, E Hachulla, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1990
[Anti-Scl-70 antibodies in systemic scleroderma]Le Thi Huong, F Sauvaget, C Johanet, et al.
The European Respiratory Journal|June 16, 2006
Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertensionM C Tamby, M Humbert, P Guilpain, et al.
Rheumatology (Oxford, England)|September 7, 2007
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitisC Lapraik, R Watts, P Bacon, et al.
Annals of the Rheumatic Diseases|November 27, 2007
Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritisX Puéchal, C Miceli-Richard, O Mejjad, et al.
The European Respiratory Journal|April 13, 2007
Severity of scleroderma lung disease is related to alveolar concentration of nitric oxideK P Tiev, J Cabane, F Aubourg, et al.
La Revue De Medecine Interne|January 23, 2004
[Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis]C Georges, O Chassany, L Mouthon, et al.
Pageof 55